Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iPROLEPSIS-PPIDC: Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study

NCT07772544 is registered in ClinicalTrials.gov with Sociedade Portuguesa de Reumatologia as lead sponsor.

NCT NCT07772544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07772544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iPROLEPSIS-PPIDC: Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study
Lead sponsor
Sociedade Portuguesa de Reumatologia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
December 31, 2027
Enrollment
72 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis (psa)